FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

New England Journal of Medicine

Volumn 365, Issue 8, 2011, Pages 768-769

  Vaccaro, Vanja ^a   Sperduti, Isabella ^a   Milella, Michele ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CISPLATIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRINOTECAN; OXALIPLATIN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DEOXYCYTIDINE; DRUG DERIVATIVE; PLATINUM COMPLEX;

CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; DRUG RESPONSE; HUMAN; LETTER; PANCREAS CANCER; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; NOTE; PANCREAS TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; DEOXYCYTIDINE; FLUOROURACIL; HUMANS; LEUCOVORIN; ORGANOPLATINUM COMPOUNDS; PANCREATIC NEOPLASMS;

EID: 80052142960     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1107627     Document Type: Letter

References (5)

1. Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011;364:1817-25.
2. Bria E, Milella M, Gelibter A, et al. Gemcitabine-based combinations for inoperable pancreatic cancer: have we made real progress? A meta-analysis of 20 phase 3 trials. Cancer 2007;110: 525-33. (Pubitemid 47106140)
3. Heinemann V, Boeck S, Hinke A, Labianca R, Louvet C. Metaanalysis of randomized trials: evaluation of benefit from gemcitabine- based combination chemotherapy applied in advanced pancreatic cancer. BMC Cancer 2008;8:82.
4. Heinemann V, Labianca R, Hinke A, Louvet C. Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/ GISCAD intergroup study and a German multicenter study. Ann Oncol 2007;18:1652-9. (Pubitemid 47514482)
5. Vaccaro V, Melisi D, Bria E, et al. Emerging pathways and future targets for the molecular therapy of pancreatic cancer. Exp Opin Target Agents (in press).